SNDX R&D to Revenue
Syndax Pharmaceuticals Inc · R&D to Revenue
SNDX R&D to Revenue
Latest reported150.15%period ending
SNDX FY R&D/Revenue (0.00% → 150.15%)
Latest values, visible window
High-resolution chart · PNG
SNDX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 150.1485% | |
| 1,020.4688% | |
| 0% | |
| 0% | |
| 63.1656% | |
| 3,324.6539% | |
| 2,834.1463% | |
| 3,962.1622% | |
| 2,286.575% | |
| 2,595.4918% | |
| 1,522.9665% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |